$0.0278
-0.00258-8.49%
Last update: Oct 30, 12:48 PM
SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. (SIGY) Stock Price, Quote, News & History
SIGYOTCPK
The Expected License Agreement Would Position Oragenics as the Only Company with Therapeutic Strategies Targeting TBI-Induced Inflammation on Both Sides of the...
You can purchase shares of SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. (OTCPK:SIGY) through any online brokerage.
There are no as such competitors for SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc..
There is no analysis for SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. to provide a consensus price target.
The stock price for SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. (OTCPK: SIGY) is $0.0278 last updated October 30, 2026 at 12:48 PM EDT.
There are no upcoming dividends for SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc..
SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc..
SIGYN THERAPEUTICS INC by Sigyn Therapeutics Inc. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.
Sigyn Therapeutics Inc is a development-stage Company advancing CardioDialysisTM, a next generation blood purification technology that enables continuous broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream. The...
